Apel Daniel Joseph
SEC CIK 2081169 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | CFO | 162.9K | — | $934.3K | 2 | 2026-01-06 | 2026-04-22 |
Most active insiders at ARWR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Anzalone Christopher Richard | CEO, Dir | — | $24.01M |
| 2 | Hamilton James C | Chief Medical Off | — | $4.63M |
| 3 | O'Brien Patrick | COO | — | $3.12M |
| 4 | PERRY MICHAEL S | Dir | — | $2.00M |
| 5 | Ferrari Mauro | Dir | — | $1.02M |
| 6 | Apel Daniel Joseph | CFO | — | $934.3K |
| 7 | OLUKOTUN ADEOYE Y | Dir | — | $850.5K |
| 8 | Vakiener Victoria | Dir | — | $679.5K |
| 9 | Waddill William D. | Dir | — | $566.0K |
| 10 | Lu Hongbo | Dir | — | $228.3K |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-04-24 18:44 | 2026-04-22 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Apel Daniel Joseph | CFO | S - Sale | $71.35 | -13.1K | 162.9K | -7% | -$934.3K |
| 2026-01-08 | 2026-01-06 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Apel Daniel Joseph | CFO | A - Grant | $0.00 | +75.0K | 176.2K | +74% | $0 |
Purchase Sale Sale after option exercise All abbreviations